The former No. 1 overall pick tested positive for a diuretic, per the report.
Suns center Deandre Ayton is facing a 25-game suspension for violating NBA’s Anti-Drug policy with a positive test for a diuretic, league sources tell ESPN. The NBA informed Ayton and Suns of looming suspension tonight.— Adrian Wojnarowski (@wojespn) October 25, 2019
It sounds like Ayton plans to appeal the suspension:
The NBPA is already preparing arbitration case to reduce or rescind penalty, based on belief positive test falls under CBA provision of ‘unintentional ingestion', league sources tell ESPN. Ayton was the No. 1 overall pick in the 2018 NBA Draft. https://t.co/UM34cCc3Ol— Adrian Wojnarowski (@wojespn) October 25, 2019
Follow-up testing on Phoenix's Deandre Ayton showed no traces of any other banned substances, sources with knowledge of results tell ESPN. NBPA is likely to fast-track arbitration process to push for a reduction as soon as possible, per sources.— Adrian Wojnarowski (@wojespn) October 25, 2019
If the suspension is upheld, it will cost Ayton roughly $2.2 million in salary. The 7-footer had 18 points and 11 rebounds in the Suns’ opener on Wednesday.
Ayton averaged 16.3 points and 10.3 rebounds per game as a rookie last season, getting named to the All-NBA Rookie First Team.
Ayton was a consensus All-American, the Pac-12 Player of the Year, Pac-12 Freshman of the Year, and the winner of the Karl Malone Award in his lone season at Arizona.